Wall Street Couldn't Stop Buying Shares of These 2 Stocks in 2020
Despite a drastic sell-off in March, the stock market had quite a year. The Nasdaq was up 44% in 2020, reminding many of the dot-com bubble, when the technology-based index posted consecutive annual gains of 40%, 23%, 22%, 40%, and 86% from 1995 through 1999.
Amidst last year's exuberance, many stocks had fantastic returns, but Novavax (NASDAQ: NVAX) and Fiverr (NYSE: FVRR) stand out as especially noteworthy. Not only were they two of the best-performing stocks among those with a market cap above $200 million, what was happening in their business gives investors a lot to look forward to in 2021.
Novavax shares climbed almost 2900% in 2020, thanks to several waves of funding and promising early stage data for a COVID-19 vaccine candidate. To design, develop, and manufacture the drug, the company initially received $388 million from the Coalition for Epidemic Preparedness Innovations (CEPI) in May. That was followed by $1.6 billion from the U.S. government's Operation Warp Speed (OWS) program in July.
Source Fool.com
